An extremely aberrant subtype of hepatitis B virus genotype D in Iran

Hepatitis Monthly

Volumn 9, Issue 1, 2009, Pages 73-75

  Mohebbi, Seyed Reza ^a,b   Amini Bavil Olyaee, Samad ^a,b,c   Zali, Narges ^a   Derakhshan, Faramarz ^a   Sabahi, Farzaneh ^b   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Genotype D; Hepatitis B virus; Hepatitis D virus; Iran; Subtype ayr

Indexed keywords

AMINO ACID; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; ASCITES; CASE REPORT; CLADISTICS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HUMAN; IRAN; LIVER CIRRHOSIS; MALE; MIXED INFECTION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRUS GENE; VIRUS ISOLATION; VIRUS TYPING;

EID: 67649336632     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24):1733-45.
2. Courouce AM, Lee H, Drouet J, Canavaggio M, Soulier JP. Monoclonal antibodies to HBsAg: a study of their specificities for eight different HBsAg subtypes. Dev Biol Stand. 1983;54:527-34.
3. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol. 1987;61(10):3030-4.
4. Norder H, Courouce AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol. 1992;73(Pt 12):3141-5.
5. Norder H, Courouce AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47(6):289-309.
6. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127(2):164-76.
7. Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sadeghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol. 2006;12(32):5211-3.
8. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, et al. Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol. 2005; 75(2):227-34.
9. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005;76(3):318-26.
10. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008;14(9):858-66.
11. Amini-Bavil-Olyaee S, Alavian SM, Adeli A, et al. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol. 2006;78(3):358-64.
12. Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology. 1997;25(3):728-34.
13. Echevarria JM, Avellon A, Magnius LO. Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol. 2005;76(2):176-84.
14. Zollner B, Petersen J, Schafer P, et al. Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment. Clin Infect Dis. 2002;34(9):1273-7.
15. Zollner B, Petersen J, Schroter M, Laufs R, Schoder V, Feucht HH. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet. 2001;357(9260):934-5.
16. Noguchi A, Hayashi J, Nakashima K, Hirata M, Ikematsu H, Kashiwagi S. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe. J Infect. 1994;28(2):141-50.